Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Doximity Stock Is Down Today

By Cory Renauer – Nov 10, 2021 at 12:13PM

Key Points

  • Doximity issued a glowing quarterly earnings report after the market closed on Tuesday, but investors looked past the results.
  • The stock is falling today in response to the impending expiration of a lock-up agreement currently keeping inside investors from selling their shares.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Third-quarter earnings were positive, but the stock market is focused on the impending end of lock-up agreements.

What happened

Shares of Doximity (DOCS -3.91%) are falling in response to the third-quarter earnings release the company issued after the market closed yesterday. The stock market looked right past its positive results and focused on the impending expiration of a 180-day lock-up agreement coming on Friday. Investors worried that insiders will dump their shares have beaten Doximity stock 11.9% lower as of 11:29 a.m. EST on Wednesday.

So what 

Shares of Doximity, a social media site for medical professionals only, soared after their initial public offering (IPO) this June, but inside investors who have the most to gain haven't been allowed to sell any of their shares yet. The stock is falling today because, in spite of sparkling third-quarter earnings results, the company told investors its 180-day lock-up agreement expires this Friday.

Investor looking at the paper.

Image source: Getty Images.

It isn't unusual for stocks to tumble around the time of their lock-up expirations. Today's fall would have been more severe if not for a glowing earnings report. 

The company did so much upselling during the fiscal second quarter, which ended Sept. 30, that it was able to register a 173% net retention rate. Revenue soared 76% year over year, and the company reported widening profit margins. Earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at 41% of revenue compared to 28% in the prior-year period. 

Now what

The bottom line is moving in the right direction fast, but it needs to keep up this pace for years to live up to this rich valuation. Despite getting knocked down today, this company's market cap is up around $12.6 billion. That works out to around 38.5 times management's top-line revenue expectations for the fiscal year ending March 31, 2022.

Doximity's stock valuation is high, but its business benefits from a strong network effect. In other words, its services become more valuable to the medical professionals who use it as more of their colleagues climb aboard. Investors want to keep this stock in a well-diversified portfolio, and this dip looks like a bargain opportunity. 

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.